EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis

2016 ◽  
Vol 294 ◽  
pp. 14-17 ◽  
Author(s):  
Hebun Erdur ◽  
Veronika Scholz ◽  
Mathias Streitz ◽  
Markus Hammer ◽  
Christian Meisel ◽  
...  
2004 ◽  
Vol 101 (8) ◽  
pp. 2428-2433 ◽  
Author(s):  
C. Skulina ◽  
S. Schmidt ◽  
K. Dornmair ◽  
H. Babbe ◽  
A. Roers ◽  
...  

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. P02.076-P02.076
Author(s):  
H. Erdur ◽  
C. Meisel ◽  
C. Schonemann ◽  
K.-P. Wandinger ◽  
B. Rosche

Brain ◽  
2002 ◽  
Vol 125 (3) ◽  
pp. 538-550 ◽  
Author(s):  
M. Jacobsen ◽  
S. Cepok ◽  
E. Quak ◽  
M. Happel ◽  
R. Gaber ◽  
...  

2002 ◽  
Vol 8 (2) ◽  
pp. 104-107 ◽  
Author(s):  
T L Sørensen ◽  
F Sellebjerg

We studied the expression of chemokine receptors CCR1, CCR2, CCR3, CCR5, and CXCR3 on CD4 and CD8 positive T cells, and on CD14 positive monocytes in blood from 10 patients with relapsing-remitting multiple sclerosis (MS) at initiation of interferon (IFN)- βtreatment, after 1 month and after 3 months of treatment. It was found that the expression of CXCR3 on CD4+ and CD8+ T cells was significantly reduced after 3 months of treatment. The expression of other receptors was unaltered. Since CXCR3 cells are enriched in cerebrospinal fluid (CSF), and are detected in lesion material in MS this may represent an important mode of action of interferon- βin MS.


2010 ◽  
Vol 134 (2) ◽  
pp. 148-157 ◽  
Author(s):  
Carol Aristimuño ◽  
Clara de Andrés ◽  
Manuel Bartolomé ◽  
Virginia de las Heras ◽  
Ma. Luisa Martínez-Ginés ◽  
...  

2002 ◽  
Vol 249 (6) ◽  
pp. 723-729 ◽  
Author(s):  
Natalia Teleshova ◽  
Mikhail Pashenkov ◽  
Yu-Min Huang ◽  
Mats Söderström ◽  
Pia Kivisäkk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document